Protocol for a mixed methods process evaluation of a hybrid implementation-effectiveness trial of a scaled-up whole-school physical activity program for adolescents: Physical Activity 4 Everyone (PA4E1).


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
17 Mar 2020
Historique:
received: 01 11 2019
accepted: 19 02 2020
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 29 12 2020
Statut: epublish

Résumé

Physical Activity 4 Everyone (PA4E1) is a physical activity program for secondary schools located in low-socioeconomic areas. Over a 24-month period, schools in the program arm of a cluster randomised controlled trial (n = up to 38 schools) will receive a multi-component implementation support strategy to embed the seven school physical activity practices of the PA4E1 program. This article describes the process evaluation of the PA4E1 hybrid implementation-effectiveness trial. The process evaluation aims to describe the fidelity and reach of the implementation support strategies using quantitative data; and to describe the acceptability, appropriateness and feasibility of the implementation support strategies and physical activity practices to school stakeholders using mixed methods. Quantitative and qualitative data will be collected from participants (Physical Education teachers, in-School Champions, students) in the program arm. Data collection will involve semi-structured interviews, focus groups, a fidelity monitoring log, a fidelity checklist, surveys, and routinely collected administrative and website data. Quantitative data will be analysed descriptively and qualitative data will be analysed thematically within and across data sets. Triangulation between data sources will be used to synthesise findings regarding the implementation and potential mechanisms of impact of PA4E1 on school physical activity practice adoption, with respect to context. Results of the process evaluation will facilitate the interpretation of the findings of the trial outcomes. It will comprehensively describe what was actually implemented and identify the potential contribution of the various components of the implementation support strategy to the school physical activity practice adoption outcomes. Findings will inform future improvement and scale-up of PA4E1 and approaches to implementing secondary school-based physical activity programs more broadly. Australian New Zealand Clinical Trials Registry ACTRN12617000681358 registered 12 May 2017.

Sections du résumé

BACKGROUND BACKGROUND
Physical Activity 4 Everyone (PA4E1) is a physical activity program for secondary schools located in low-socioeconomic areas. Over a 24-month period, schools in the program arm of a cluster randomised controlled trial (n = up to 38 schools) will receive a multi-component implementation support strategy to embed the seven school physical activity practices of the PA4E1 program. This article describes the process evaluation of the PA4E1 hybrid implementation-effectiveness trial. The process evaluation aims to describe the fidelity and reach of the implementation support strategies using quantitative data; and to describe the acceptability, appropriateness and feasibility of the implementation support strategies and physical activity practices to school stakeholders using mixed methods.
METHODS METHODS
Quantitative and qualitative data will be collected from participants (Physical Education teachers, in-School Champions, students) in the program arm. Data collection will involve semi-structured interviews, focus groups, a fidelity monitoring log, a fidelity checklist, surveys, and routinely collected administrative and website data. Quantitative data will be analysed descriptively and qualitative data will be analysed thematically within and across data sets. Triangulation between data sources will be used to synthesise findings regarding the implementation and potential mechanisms of impact of PA4E1 on school physical activity practice adoption, with respect to context.
DISCUSSION CONCLUSIONS
Results of the process evaluation will facilitate the interpretation of the findings of the trial outcomes. It will comprehensively describe what was actually implemented and identify the potential contribution of the various components of the implementation support strategy to the school physical activity practice adoption outcomes. Findings will inform future improvement and scale-up of PA4E1 and approaches to implementing secondary school-based physical activity programs more broadly.
TRIAL REGISTRATION BACKGROUND
Australian New Zealand Clinical Trials Registry ACTRN12617000681358 registered 12 May 2017.

Identifiants

pubmed: 32183902
doi: 10.1186/s13063-020-4187-5
pii: 10.1186/s13063-020-4187-5
pmc: PMC7077014
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

268

Subventions

Organisme : NSW Ministry of Health (AU)
ID : H16/22534

Références

Am J Health Promot. 1996 Mar-Apr;10(4):270-81
pubmed: 10159708
Front Public Health. 2014 May 20;2:42
pubmed: 24904909
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
J Public Health (Oxf). 2019 Dec 12;:
pubmed: 31832667
Br J Sports Med. 2011 Sep;45(11):923-30
pubmed: 21836176
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Prev Med. 2015 Mar;72:95-115
pubmed: 25575800
Circulation. 2006 Sep 12;114(11):1214-24
pubmed: 16908770
Lancet. 2012 Jul 21;380(9838):247-57
pubmed: 22818937
Implement Sci. 2013 Jun 10;8:65
pubmed: 23758995
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Int J Behav Nutr Phys Act. 2009 Nov 30;6:79
pubmed: 19948049
Obes Rev. 2017 Apr;18(4):476-490
pubmed: 28187241
BMJ. 2010 Sep 17;341:c4587
pubmed: 20851841
Int J Behav Nutr Phys Act. 2016 Aug 22;13:94
pubmed: 27549382
Lancet. 2016 Sep 24;388(10051):1311-24
pubmed: 27475266
Implement Sci. 2019 Feb 18;14(1):17
pubmed: 30777080
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Am J Prev Med. 2016 Aug;51(2):195-205
pubmed: 27103495
Health Promot J Austr. 2016 Feb;27(3):204-207
pubmed: 29241482
BMC Public Health. 2019 Jul 4;19(1):883
pubmed: 31272421
Int J Obes (Lond). 2016 Oct;40(10):1486-1493
pubmed: 27430652
Trials. 2018 May 21;19(1):282
pubmed: 29784016
Cochrane Database Syst Rev. 2017 Nov 29;11:CD011677
pubmed: 29185627
Implement Sci. 2019 Jun 6;14(1):58
pubmed: 31171014
BMC Public Health. 2016 Apr 21;16:349
pubmed: 27097646
BMC Public Health. 2016 Jan 14;16:37
pubmed: 26769240
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
BMC Public Health. 2013 Jan 22;13:57
pubmed: 23336603
Obes Facts. 2009;2(3):187-95
pubmed: 20054224
Obes Rev. 2019 Jun;20(6):859-870
pubmed: 30628172
Front Public Health. 2018 Apr 09;6:102
pubmed: 29686983
Prev Med. 2018 Feb;107:45-53
pubmed: 29155228

Auteurs

Matthew Mclaughlin (M)

Hunter New England Population Health, Longworth Avenue, Wallsend, 2287, NSW, Australia. matthew.mclaughlin@hnehealth.nsw.gov.au.
School of Medicine and Public Health, University of Newcastle, University Dr, Callaghan, NSW, 2308, Australia. matthew.mclaughlin@hnehealth.nsw.gov.au.
Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights, 2305, NSW, Australia. matthew.mclaughlin@hnehealth.nsw.gov.au.
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, 2308, NSW, Australia. matthew.mclaughlin@hnehealth.nsw.gov.au.

Jed Duff (J)

School of Medicine and Public Health, University of Newcastle, University Dr, Callaghan, NSW, 2308, Australia.

Rachel Sutherland (R)

Hunter New England Population Health, Longworth Avenue, Wallsend, 2287, NSW, Australia.
School of Medicine and Public Health, University of Newcastle, University Dr, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights, 2305, NSW, Australia.
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, 2308, NSW, Australia.

Elizabeth Campbell (E)

Hunter New England Population Health, Longworth Avenue, Wallsend, 2287, NSW, Australia.
School of Medicine and Public Health, University of Newcastle, University Dr, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights, 2305, NSW, Australia.
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, 2308, NSW, Australia.

Luke Wolfenden (L)

Hunter New England Population Health, Longworth Avenue, Wallsend, 2287, NSW, Australia.
School of Medicine and Public Health, University of Newcastle, University Dr, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights, 2305, NSW, Australia.
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, 2308, NSW, Australia.

John Wiggers (J)

Hunter New England Population Health, Longworth Avenue, Wallsend, 2287, NSW, Australia.
School of Medicine and Public Health, University of Newcastle, University Dr, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights, 2305, NSW, Australia.
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, 2308, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH